Saturday, October 19, 2019
wellness India Expo
Home Tags Dr Kiran Mazumdar Shaw

Tag: Dr Kiran Mazumdar Shaw

Syngene International & BIRAC set up Centre for Advanced Protein Studies

The Centre has been set up at Syngene’s campus in Bengaluru by the Biotechnology Industry Research Assistance Council (BIRAC) and will host a state-of-the-art GLP accredited analytical laboratory. The collaboration a part of National Biopharma Mission.............

Science & technology play a central role in societal development

LMSAI- Harvard University collaborated with the office of Scientific Adviser to Government of India and NITI Aayog to host annual India symposium on ‘Science & Society’ on 4th April at New Delhi..................

India showcases its biotech power at BIO Boston

The world’s largest gathering of the biotechnology industry witnessed a record 17,000 participants over the 4 days of the event held at Boston in the United States of America...................

Biocon & Mylan’s biosimilar ‘Trastuzumab’ gets approval from Brazilian regulator

Co-developed by Biocon and Mylan, this is the first biosimilar Trastuzumab to be approved in Brazil and is indicated for the treatment of overexpressing HER2­positive metastatic breast cancer. The product will be marketed by the Libbs Farmaceutica........

BIRAC celebrates its 5th birthday amid resolve to make India a...

The intense discussions at the 2-day event to celebrate the 5th foundation day of the Biotechnology Research Assistance Council, were focused around the theme “[email protected]: Impacting the Biotech Ecosystem”........

ABLE selects BEST student entrepreneurial teams for 2016

ABLE announces BEST 2016 winners, the annual list of five teams comprising of young post graduate teams who wish to pursue the spirit of biotech innovation and business......

US-FDA accepts Mylan & Biocon’s joint application on biosimilar Trastuzumab

While the Biologics License Application (BLA) for MYL-1401O has been accepted by the United States FDA, if approved, it has the potential to be the first biosimilar Trastuzumab in the US....

BioVoice eMag December 2016 – January 2017 Issue-8 Volume-1

BioVoice eMag December 2016 - January 2017 Issue-8 Volume-1: This edition of BioVoice features detailed cover story on demonetization move and the immediate steps taken...

Dr Kas Subramanian joins Syngene International

Having headed the R&D division at the Strand Life Sciences, Dr Kalyanasundaram Subramanian will now spearhead the bioinformatics initiative....

Biocon registers strong performance, profits up by 17%

Biocon in the first quarter of the financial year 2016-17, has reported the revenues of Rs 952 crore; net profit up by 17 percent at Rs 147 crore ....